Collavera
Gel · Topical
Uses
Collavera™ is indicated for topical analgesia as directed by a healthcare provider.
Dosage and administration
For topical use only. Apply a thin layer to the affected area 3 to 4 times daily or as directed by a healthcare provider. Avoid contact with eyes and mucous membranes.
Warnings
For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in systemic absorption. Use only as directed. Keep out of reach of children.
Overdosage
Excessive topical application may increase systemic absorption of lidocaine and may result in central nervous system and cardiovascular effects. In the event of overdose, discontinue use and seek medical attention.
Description
Collavera™ contains Lidocaine Hydrochloride 20 mg/g (2%) in a topical gel base.
How supplied
Collavera™ (Lidocaine Hydrochloride 20 mg/g) is supplied as a clear topical gel in a 1 oz (28.33 g) tube. NDC 85477-305-07
Label text from the FDA structured product label by Oncora Pharma, LLC (revised Feb 27, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Lidocaine in 1 product
Collavera NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 85477-305 | Lidocaine 20 mg/g Gel | Oncora Pharma, LLC | UNAPPROVED DRUG OTHER |
Frequently asked questions
What is Collavera used for?
Collavera™ is indicated for topical analgesia as directed by a healthcare provider.
Who makes Collavera?
Collavera is listed by 1 labeler in the FDA NDC directory, including Oncora Pharma, LLC.